Standard Process Issues Voluntary Recall of Three Supplements Because of Possible Health Risk

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: Standard Process Issues Voluntary Recall of Three Supplements Because of Possible Health Risk

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

Standard Process Issues Voluntary Recall of Three Supplements Because of Possible Health Risk

06/29/2012 05:02 PM EDT

Standard Process Inc. of Palmyra, WI 53156 is voluntarily recalling the following three dietary supplements due to potential Salmonella contamination: Cataplex ACP (Product number 0700 and 0750) Lot 114 Cataplex C (Product number 1650 1655) Lot 114 Pancreatrophin PMG (Product number 6650) Lot 114 The products, all tablets, were distributed in 60 cc and 200 cc amber glass bottles with Best Used By dates (BUB) of 5/13 indicated on both the bottles and the boxes.

. For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? support@xxxxxxxxxxxxxxx
• Other inquiries? webmail@xxxxxxxxxx

---

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420